This study not only identifies Androgen Receptor as a target of RNase L regulation, but also demonstrates that the effect of HPC1-associated mutations on AR signaling and cell migration is amenable to regulation by physiological conditions that exist in prostate cancer cells. Here, STX1A is linked to prostate carcinoma.